- 89 percent of the public favors requiring the Food and Drug Administration [FDA] to review prescription-drug ads for accuracy before they are broadcast.
- A survey of patients by Prevention Magazine in 2012 showed that [inlinetweet prefix=”” tweeter=”” suffix=””]71 percent of people agree that DTC advertisements “allow people to be more involved with their health care” and 75 percent believe that DTC ads are useful because they “tell people about new treatments.[/inlinetweet]
- Prevention’s survey also found that [inlinetweet prefix=”” tweeter=”” suffix=””]76 percent of Americans talked to their physicians about a condition after seeing a DTC ad [/inlinetweet]and among those who discussed a specific medicine that was advertised with their physician, [inlinetweet prefix=”” tweeter=”” suffix=””]only 20 percent received the prescription of the advertised medicine.[/inlinetweet]
- Fair balance in DTC TV ads is not necessary as the vast majority of patients will go online to learn about drug side effects.
- Drug companies are left out of social media conversations because they lack FDA guidelines.
There was a time when people would run off to their doctor to ask for an advertised prescription drug. Those days are pretty much over. Today, as research continually shows, people do their homework before asking about a prescription drug and with so many drugs being marketed for the same health conditions, [inlinetweet prefix=”” tweeter=”” suffix=””]many people are just not willing to go through the hassle of switching meds unless there is a clear benefit or lower cost.[/inlinetweet]
Fair balance within TV ads is a waste of time and money. What the FDA fails to understand is that patients are smart enough to do their homework BEFORE requesting an advertised drug. Today DTC ads drive people online to learn more before driving them to their doctor to ask about/for the medication.
A lot of the consulting that I do is to provide brands with a dashboard around social media conversations with implications and reach. The conversations are happening and a lot of them are based on inaccurate information, but too many drug companies are staying out of the conversation because they are afraid of repercussions from the FDA. The idea that drug companies need to provide fair balance on social media is dated. It should be one click away.
Two months ago, in research, I heard that online health seekers still use the safety page on drug websites, but the problem, but they also complained that the safety information was too long and too hard to read. When asked “where do you go for drug side effects” the prominent answer was “social media”. We asked about the credibility of health information within social media and online health seekers were basically split. Some said they trust the info, but would do more research while others said they would use what’s being said to help them make treatment decisions.
Drug companies owe it to online health seekers to be part of the query for health information online. By providing credible sources of health information and talking to patients one-on-one they can start down the road to earning trust.
The FDA needs to recruit DRG Research to come in and present their data so they can better understand the real world factors that influence patients’ health choices. Until they do, guidelines will continue to remain stuck in the past.